MGMT and glioblastoma: To further explore the clinical application value of the RBP signature, we next constructed a nomogram based on the independent prognostic factors (age, chemotherapy, MGMT promoter status, and risk score) of GBM in the TCGA training cohort (n = 259) (Fig. 5A).